体外诊断成分股数据 申万3级
851534.SI (39)
数据更新时间：2025-09-18
"-"表示无或者负数
| 序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值（亿元）
|
归母净利润同比增长(06-30)
|
归母净利润同比增长(03-31)
|
营业收入同比增长(06-30)
|
营业收入同比增长(03-31)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 002932.SZ | 明德生物 | 2018-07-17 | — | — | 体外诊断 | 18.89 | 58.94 | 200.98 | 0.79 | 6.15% | 43.92 | -80.82% | -111.43% | -9.71% | 14.76% |
| 2 | 688389.SH | 普门科技 | 2023-09-25 | — | — | 体外诊断 | 14.0 | 17.37 | 20.33 | 2.92 | — | 59.99 | -29.27% | -49.93% | -14.08% | -29.70% |
| 3 | 002086.SZ | 东方海洋 | 2024-01-02 | — | — | 体外诊断 | 2.76 | — | — | 3.97 | — | 54.07 | -71.23% | -53.58% | 0.34% | 12.95% |
| 4 | 300439.SZ | 美康生物 | 2015-04-29 | — | — | 体外诊断 | 10.54 | 15.7 | 29.7 | 1.37 | 1.28% | 40.51 | -68.15% | -61.57% | -22.43% | -22.32% |
| 5 | 002030.SZ | 达安基因 | 2004-08-16 | — | — | 体外诊断 | 6.33 | — | — | 1.15 | — | 88.84 | 54.37% | 114.57% | -15.44% | -14.71% |
| 6 | 688253.SH | 英诺特 | 2023-09-25 | — | — | 体外诊断 | 31.02 | 17.15 | 25.55 | 2.1 | — | 42.33 | -39.36% | -34.77% | -34.35% | -26.51% |
| 7 | 300642.SZ | 透景生命 | 2017-04-28 | — | — | 体外诊断 | 25.73 | 121.11 | 136.42 | 2.81 | 0.58% | 41.83 | -58.41% | 110.51% | -26.25% | -19.53% |
| 8 | 600645.SH | 中源协和 | 1999-12-30 | — | — | 体外诊断 | 24.78 | 115.55 | 158.98 | 3.18 | — | 115.96 | -32.18% | -30.18% | -10.71% | -11.86% |
| 9 | 688606.SH | 奥泰生物 | 2023-09-25 | — | — | 体外诊断 | 67.09 | 17.58 | 17.12 | 1.36 | — | 53.19 | 6.57% | 36.68% | 8.41% | 4.28% |
| 10 | 688217.SH | 睿昂基因 | 2023-09-25 | — | — | 体外诊断 | 27.82 | — | — | 1.7 | — | 15.54 | -61.46% | 529.26% | -22.29% | -14.72% |
| 11 | 688068.SH | 热景生物 | 2023-09-25 | — | — | 体外诊断 | 178.08 | — | — | 5.62 | — | 165.09 | -93.24% | -574.96% | -18.04% | -19.71% |
| 12 | 300942.SZ | 易瑞生物 | 2021-02-23 | — | — | 体外诊断 | 10.89 | 257.72 | 209.9 | 5.32 | 0.16% | 44.11 | 250.02% | 52.95% | 5.44% | 35.28% |
| 13 | 002022.SZ | 科华生物 | 2004-07-28 | — | — | 体外诊断 | 6.58 | — | — | 1.06 | — | 33.84 | -154.37% | -84.79% | -12.65% | -12.50% |
| 14 | 688298.SH | 东方生物 | 2023-09-25 | — | — | 体外诊断 | 26.36 | — | — | 0.82 | — | 53.14 | -7.58% | -71.41% | -3.62% | 4.94% |
| 15 | 688399.SH | 硕世生物 | 2023-09-25 | — | — | 体外诊断 | 67.14 | — | — | 1.9 | — | 56.31 | -86.35% | -68.01% | -1.05% | 0.54% |
| 16 | 688575.SH | 亚辉龙 | 2023-09-25 | — | — | 体外诊断 | 14.79 | 27.98 | 54.51 | 3.16 | — | 84.37 | -84.82% | -84.63% | -15.79% | -3.13% |
| 17 | 688393.SH | 安必平 | 2023-09-25 | — | — | 体外诊断 | 27.58 | 121.2 | — | 2.1 | — | 25.81 | -176.38% | -238.49% | -30.11% | -28.51% |
| 18 | 688468.SH | 科美诊断 | 2023-09-25 | — | — | 体外诊断 | 7.85 | 24.78 | 42.11 | 2.26 | — | 31.49 | -68.24% | -62.12% | -27.03% | -27.01% |
| 19 | 688338.SH | 赛科希德 | 2023-09-25 | — | — | 体外诊断 | 26.82 | 25.19 | 28.97 | 1.73 | — | 28.47 | -23.47% | -23.98% | -12.62% | -9.47% |
| 20 | 688317.SH | 之江生物 | 2023-09-25 | — | — | 体外诊断 | 24.69 | — | — | 1.38 | — | 47.44 | -137.88% | -159.53% | -36.91% | -37.27% |
| 21 | 688067.SH | 爱威科技 | 2023-09-25 | — | — | 体外诊断 | 26.17 | 77.91 | 70.35 | 3.54 | — | 17.80 | 21.16% | 24.63% | 12.70% | 13.85% |
| 22 | 300463.SZ | 迈克生物 | 2015-06-04 | — | — | 体外诊断 | 11.93 | 56.89 | — | 1.15 | 0.88% | 72.14 | -83.12% | -80.09% | -15.94% | -17.22% |
| 23 | 688426.SH | 康为世纪 | 2024-07-31 | — | — | 体外诊断 | 27.66 | — | — | 2.21 | — | 31.12 | -11.70% | 21.49% | 29.74% | 49.31% |
| 24 | 688193.SH | 仁度生物 | 2023-09-25 | — | — | 体外诊断 | 46.62 | — | — | 2.05 | — | 18.68 | -52.94% | -67.04% | -6.27% | -9.22% |
| 25 | 300832.SZ | 新产业 | 2020-05-19 | — | — | 体外诊断 | 68.57 | 29.47 | 31.76 | 6.48 | 1.9% | 538.77 | -14.62% | 2.65% | -1.18% | 10.12% |
| 26 | 300685.SZ | 艾德生物 | 2017-08-09 | — | — | 体外诊断 | 22.92 | 35.21 | 29.91 | 4.76 | 1.31% | 89.74 | 31.41% | 40.92% | 6.69% | 16.63% |
| 27 | 300396.SZ | 迪瑞医疗 | 2014-09-17 | — | — | 体外诊断 | 13.68 | 26.29 | — | 1.91 | 1.9% | 37.31 | -117.13% | -87.13% | -60.07% | -72.47% |
| 28 | 300406.SZ | 九强生物 | 2014-11-06 | — | — | 体外诊断 | 13.67 | 15.05 | 17.52 | 2.16 | 5.1% | 80.15 | -30.01% | -30.99% | -18.67% | -18.81% |
| 29 | 603387.SH | 基蛋生物 | 2017-07-24 | — | — | 体外诊断 | 8.27 | 18.75 | 22.59 | 1.59 | 2.18% | 41.94 | -25.88% | -25.24% | -17.00% | -24.08% |
| 30 | 002432.SZ | 九安医疗 | 2022-08-01 | — | — | 体外诊断 | 38.74 | 11.02 | 9.25 | 0.84 | 0.47% | 183.85 | 52.91% | 7.62% | -43.35% | -33.49% |
| 31 | 300289.SZ | 利德曼 | 2012-02-23 | — | — | 体外诊断 | 7.84 | — | — | 2.57 | — | 42.65 | -800.43% | 53.73% | -14.80% | -16.61% |
| 32 | 603658.SH | 安图生物 | 2016-09-08 | — | — | 体外诊断 | 40.51 | 19.38 | 20.2 | 2.74 | 3.11% | 231.48 | -7.83% | -16.76% | -6.65% | -8.56% |
| 33 | 300482.SZ | 万孚生物 | 2015-07-07 | — | — | 体外诊断 | 21.69 | 18.08 | 25.7 | 1.92 | 1.9% | 101.53 | -46.82% | -13.37% | -20.92% | -7.06% |
| 34 | 688289.SH | 圣湘生物 | 2023-09-25 | — | — | 体外诊断 | 20.24 | 42.55 | 41.64 | 1.62 | — | 117.27 | 3.84% | 13.22% | 21.15% | 21.62% |
| 35 | 300639.SZ | 凯普生物 | 2017-04-19 | — | — | 体外诊断 | 5.79 | — | — | 0.96 | — | 37.43 | -16.46% | -90.21% | -22.96% | -26.78% |
| 36 | 600807.SH | 济高发展 | 2024-07-31 | — | — | 体外诊断 | 3.26 | — | — | 42.91 | — | 28.84 | -57.51% | -48.99% | -23.36% | 57.81% |
| 37 | 688656.SH | 浩欧博 | 2023-09-25 | — | — | 体外诊断 | 171.0 | 294.94 | 374.42 | 13.33 | — | 108.55 | -39.10% | -56.97% | -6.48% | -9.33% |
| 38 | 688767.SH | 博拓生物 | 2023-09-25 | — | — | 体外诊断 | 42.68 | 37.6 | 58.08 | 2.74 | — | 63.74 | -82.82% | -77.97% | -23.91% | -35.20% |
| 39 | 688075.SH | 安旭生物 | 2023-09-25 | — | — | 体外诊断 | 38.7 | 25.58 | 36.09 | 0.95 | — | 49.18 | -48.57% | -51.52% | -7.42% | -10.90% |
免责声明：数据相关栏目所收集数据，均来自第三方个人或企业公开数据以及国家统计网站公开发布数据，数据由计算机技术自动收集更新再由作者校验，作者将尽力校验，但不能保证数据的完全准确。 阅读本栏目的用户必须明白，图表所示结果或标示仅供学习参考使用，均不构成交易依据。任何据此进行交易等行为，而引致的任何损害后果，本站概不负责。
关注微信公众号
获取更多数据
获取更多数据
关闭 X